01.07.2013 Views

Recent Advances in Angiogenesis and ... - Bentham Science

Recent Advances in Angiogenesis and ... - Bentham Science

Recent Advances in Angiogenesis and ... - Bentham Science

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

12 <strong>Recent</strong> <strong>Advances</strong> <strong>in</strong> <strong>Angiogenesis</strong> <strong>and</strong> Antiangiogenesis, 2009 Leali <strong>and</strong> Nald<strong>in</strong>i<br />

OPN acts also as a substrate for matrix<br />

metalloproteases MMP-3 <strong>and</strong> MMP-7, <strong>and</strong> the cleaved<br />

fragments enhanced adhesion <strong>and</strong> migration <strong>in</strong> vitro<br />

through ligation of receptors <strong>in</strong>clud<strong>in</strong>g 1<strong>in</strong>tegr<strong>in</strong> [54].<br />

Indeed, there are two different b<strong>in</strong>d<strong>in</strong>g sites for 41<br />

<strong>in</strong>tegr<strong>in</strong> present <strong>in</strong> a 38-am<strong>in</strong>o acid doma<strong>in</strong> with<strong>in</strong> the<br />

N-term<strong>in</strong>al thromb<strong>in</strong> fragment, correspond<strong>in</strong>g to both<br />

162 SVVYGLR 168 <strong>and</strong> 131 ELVTDFPTDLPAT 143 motifs<br />

[55]. Furthermore, the sequence 43 WLNPDP 48 has<br />

been recently described as a novel functional motif of<br />

OPN, <strong>in</strong>volved <strong>in</strong> migration <strong>and</strong> survival of human<br />

lymphocyte, although the correspond<strong>in</strong>g <strong>in</strong>teract<strong>in</strong>g<br />

receptor has not been identified [56].<br />

A<br />

17<br />

HN 2<br />

N-term<strong>in</strong>us<br />

131 ELVTDFPTDLPAT 143<br />

a1b1 158 168<br />

GRGDSVVYGLR<br />

a1b1,<br />

a1b1 a1<br />

b1,<br />

a1<br />

b1<br />

a b a b<br />

1 1, 1 1<br />

Thromb<strong>in</strong><br />

168 169<br />

R<br />

a1b1<br />

a1b1<br />

a b<br />

1 1<br />

C-term<strong>in</strong>us<br />

CD44v6, CD44v6-v7,<br />

CD44v3, (hepar<strong>in</strong> bridge)<br />

MMP-3,7<br />

1 MRIAVICFCLLGITCAIPVKQADSGSSEEKQLYNKYPDAV<br />

41 ATWLNPDPSQKQNLLAPQNAVSSEETNDFKQETLPSKSNE<br />

Fig. (1). OPN prote<strong>in</strong> structure. (A) Schematic<br />

representation of the human OPN prote<strong>in</strong>. OPN conta<strong>in</strong>s<br />

a thromb<strong>in</strong> cleavage site that separates the Nterm<strong>in</strong>us/<strong>in</strong>tegr<strong>in</strong><br />

b<strong>in</strong>d<strong>in</strong>g <strong>and</strong> the C-term<strong>in</strong>us/CD44v<br />

b<strong>in</strong>d<strong>in</strong>g doma<strong>in</strong>s (am<strong>in</strong>o acid residues 17-168 <strong>and</strong> 169-<br />

314, respectively). Conserved regions <strong>in</strong>volved <strong>in</strong><br />

receptor <strong>in</strong>teractions are <strong>in</strong>dicated. (B) Am<strong>in</strong>o acid<br />

sequence (s<strong>in</strong>gle letter code) of the human OPN prote<strong>in</strong><br />

(GenBank accession number: J04765). The N-term<strong>in</strong>us<br />

<strong>and</strong> C-term<strong>in</strong>us doma<strong>in</strong>s are underl<strong>in</strong>ed <strong>and</strong> shown as<br />

dotted l<strong>in</strong>e, respectively. The signal sequence (am<strong>in</strong>o acid<br />

residues 1-16) is <strong>in</strong> Italics. Arrow <strong>in</strong>dicates the thromb<strong>in</strong><br />

cleavage site.<br />

In keep<strong>in</strong>g with its ability to associate with different<br />

ECM prote<strong>in</strong>s, such as collagen <strong>and</strong> fibronect<strong>in</strong><br />

[57,58], a novel functional doma<strong>in</strong>, spann<strong>in</strong>g both the<br />

SK<br />

314<br />

COOH<br />

81 SHDHMDDMDDEDDDDHVDSQDSIDSNDSDDVDDTDDSHQS<br />

121 DESHHSDESDELVTDFPTDLPATEVFTPVVPTVDTYDGRG<br />

161 DSVVYGLRSKSKKFRRPDIQYPDATDEDITSHMESEELNG<br />

201 AYKAIPVAQDLNAPSDWDSRGKDSYETSQLDDQSAETHSH<br />

241 KQSRLYKRKANDESNEHSDVIDSQELSKVSREFHSHEFHS<br />

281 HEDMLVVDPKSKEEDKHLKFRISHELDSASSEVN<br />

B<br />

NH2-term<strong>in</strong>al <strong>and</strong> the C-term<strong>in</strong>al regions of the<br />

prote<strong>in</strong>, has been recently identified as “collagen<br />

b<strong>in</strong>d<strong>in</strong>g motif”, correspond<strong>in</strong>g to the<br />

166 GLRSKSKKFRRPDIQYPDATDEDITSHM 193<br />

sequence <strong>in</strong> human OPN [59].<br />

The C-term<strong>in</strong>al fragment of OPN conta<strong>in</strong>s a conserved<br />

calcium b<strong>in</strong>d<strong>in</strong>g site <strong>and</strong> <strong>in</strong>teracts directly with<br />

CD44v6- <strong>and</strong> v7-conta<strong>in</strong><strong>in</strong>g isoforms [44,60],<br />

although CD44v3 might <strong>in</strong>directly b<strong>in</strong>d OPN through<br />

a hepar<strong>in</strong> bridge [52]. This RGD-<strong>in</strong>dependent<br />

<strong>in</strong>teraction appears to require the presence of 1<br />

<strong>in</strong>tegr<strong>in</strong>s [61]. It has been recently proposed a model<br />

for human OPN structure <strong>in</strong> which a sequence <strong>in</strong> the<br />

C-term<strong>in</strong>al region forms a -sheet structure with the<br />

RGDSVVYGLR doma<strong>in</strong> <strong>in</strong> the N-term<strong>in</strong>us, thus<br />

<strong>in</strong>terfer<strong>in</strong>g with RGD-<strong>in</strong>tegr<strong>in</strong> <strong>in</strong>teraction [46]. This<br />

model might expla<strong>in</strong> the ability of monoclonal<br />

antibody aga<strong>in</strong>st the C-term<strong>in</strong>us doma<strong>in</strong> to <strong>in</strong>hibit cell<br />

adhesion to OPN, thus suggest<strong>in</strong>g the possibility that<br />

CD44/OPN <strong>in</strong>teraction modulates the cells’ capacity to<br />

recognize the RGD sequence [62].<br />

Although expressed as a ~ 33 kDa nascent prote<strong>in</strong>,<br />

extensive posttranslational modifications (PTMs) such<br />

as Ser/Thr phosphorylation, O-l<strong>in</strong>ked/N-l<strong>in</strong>ked<br />

glycosylation, sialylation, Tyr sulfation <strong>and</strong> enzymatic<br />

cleavage, <strong>in</strong>crease its apparent molecular weight, thus<br />

determ<strong>in</strong><strong>in</strong>g a prote<strong>in</strong> migration <strong>in</strong> SDS-PAGE gels <strong>in</strong><br />

the range of 44-80 kDa depend<strong>in</strong>g on conditions<br />

[24,63]. Polymeric form of OPN has been recently<br />

reported which produces a b<strong>and</strong> around 200 kDa that<br />

is mediated by transglutam<strong>in</strong>ase [64,65]. Many sites of<br />

PTMs are conserved across species; however, the<br />

degree of modification of the prote<strong>in</strong> varies depend<strong>in</strong>g<br />

on the source tissue <strong>and</strong> cell type or differentiation<br />

stage [66-68] <strong>and</strong> <strong>in</strong>fluence OPN function [46].<br />

Phosphorylation of OPN appears necessary for various<br />

physiological functions, <strong>in</strong>clud<strong>in</strong>g migration of cancer<br />

cells [69], adhesion <strong>and</strong> bone resorption by osteoclasts<br />

[70], <strong>in</strong>hibition of smooth muscle cell calcification<br />

[71] <strong>and</strong> regulation of m<strong>in</strong>eralization [72]. The<br />

phosphorylation of OPN is usually heterogeneous, <strong>and</strong><br />

it is not known whether certa<strong>in</strong> specific sites are<br />

critical for a given function; furthermore, it is possible<br />

that differences <strong>in</strong> OPN post-translational modification<br />

status, together with variations <strong>in</strong> the target cell<br />

receptor repertoire, modulate OPN’s functions or the<br />

cellular response to OPN [46].<br />

4. OPN SIGNALING<br />

The role of both secreted <strong>and</strong> <strong>in</strong>tracellular OPN <strong>in</strong> cell<br />

signal<strong>in</strong>g has been recently reviewed <strong>in</strong> the context of<br />

cancer progression <strong>and</strong> immune response [40,73].<br />

Many of the signal<strong>in</strong>g pathways mediated by secreted<br />

OPN are activated by ligation of the <strong>in</strong>tegr<strong>in</strong> <strong>and</strong><br />

CD44 families of receptors. OPN signal<strong>in</strong>g through

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!